Printer Friendly Version View printer-friendly version
<< Back
Array BioPharma to Present at the JP Morgan 28th Annual Healthcare Conference
BOULDER, Colo., Jan 04, 2010 (BUSINESS WIRE) -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the JP Morgan 28th Annual Healthcare Conference in San Francisco. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.


J.P. Morgan 28th Annual Healthcare Conference


Robert E. Conway, Chief Executive Officer, Array BioPharma


Wednesday, January 13, 2010


3 p.m. Pacific Time


Westin St. Francis, San Francisco


About Array BioPharma

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer, inflammatory diseases, pain and metabolic diseases. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at significant unmet medical needs. For more information on Array, please go to

SOURCE: Array BioPharma Inc.

Array BioPharma Inc.
Tricia Haugeto, 303-386-1193